The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone

The aim of the present study was to evaluate the potential antidiabetic effects of two-component drug Subetta and its components (release-active dilutions of antibodies to β-subunit insulin receptor (RAD of Abs to β-InsR) and to endothelial nitric oxide synthase (RAD of Abs to eNOS)) in Goto-Kakizak...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailbé, Danielle, Philippe, Erwann, Gorbunov, Evgeniy, Tarasov, Sergey, Epstein, Oleg, Portha, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665238/
https://www.ncbi.nlm.nih.gov/pubmed/23762875
http://dx.doi.org/10.1155/2013/763125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665238/
https://www.ncbi.nlm.nih.gov/pubmed/23762875
http://dx.doi.org/10.1155/2013/763125

Ejemplares similares